Related Experiment Video
Updated: Aug 20, 2025

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
Complications of COVID-19 Vaccines during Pregnancy; a Systematic Review
SeyedAhmad SeyedAlinaghi1, Mehrzad MohsseniPour1, Solmaz Saeidi2
1Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Insights
COVID-19 vaccination in pregnant women generally showed positive impacts with few negative effects. However, limited data prevents definitive conclusions on adverse outcomes, necessitating further research.
Area of Science:
- Immunology
- Obstetrics and Gynecology
- Public Health
Background:
- COVID-19 vaccination expanded to include pregnant women.
- Concerns exist regarding potential pregnancy complications and maternal outcomes post-vaccination.
- Existing research on this topic requires systematic review.
Purpose of the Study:
- To review existing literature on pregnancy complications and maternal outcomes following COVID-19 vaccination in pregnant women.
- To synthesize available data on the safety and adverse events associated with COVID-19 vaccines during pregnancy.
Main Methods:
- Systematic literature search of PubMed, Scopus, Cochrane, and Web of Science databases up to August 31, 2022.
- Two-step screening process (title/abstract, then full-text) for eligible English original studies.
- Data extraction on study design, vaccine type, gestational age, maternal health, and post-vaccination complications.
Main Results:
- Most studies indicated a positive impact of vaccination with no observed negative effects.
- A subset of studies reported no maternal underlying diseases.
- Rare serious adverse events included miscarriage, preterm birth, and congenital anomalies.
Conclusions:
- Limited data and study designs hinder definitive conclusions on causation between vaccines and adverse effects.
- Certain adverse outcomes in vaccinated pregnant women cannot be commented on with certainty.
- Further longitudinal and experimental studies are required to establish the exact adverse effects of COVID-19 vaccines in pregnant populations.
Introduction:
Rare serious complications have been documented after COVID-19 vaccination as clinical research proceeded and new target populations, such as children and pregnant women, were included. In this study, we attempted to review the literature relevant to pregnancy complications and maternal outcomes of COVID-19 immunization in pregnant women. .
Methods:
We searched the databases of PubMed, Scopus, Cochrane, and Web of Science on 31 August 2022. The records were downloaded and underwent a two-step screening; 1) title/abstract and then 2) full-text screening to identify the eligible studies. We included English original studies that evaluated the adverse effects of COVID-19 vaccines during pregnancy. Information such as the type of study, geographical location, type of vaccine injected, gestational age, maternal underlying diseases, and complications following the vaccination were extracted into pre-designed tables.
Results:
According to the findings of included studies, in most of them vaccination had a positive impact and no negative effects were observed. Also, no medical history was reported in 11 articles, and pregnant women had no underlying diseases. Some serious adverse events were reported after vaccination, including miscarriage, paresthesia, uterine contraction, vaginal bleeding, preterm birth, major congenital anomalies, intrauterine growth restriction, and seizure. .
Conclusion:
Because of limited data availability and the cross-sectional design of most studies, we could neither infer causation between vaccines and incidence of adverse effects nor comment with certainty about any possible adverse outcome of COVID-19 vaccines in vaccinated pregnant women. Consequently, more longitudinal and experimental studies are needed to define the exact adverse effects of COVID-19 vaccines in pregnant women.
More Related Videos
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Vaccinations
Mitral Valve Prolapse III: Nursing Management
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...